'Cure' of life-threatening antiphospholipid syndrome with rituximab [3]

Internal Medicine Journal

Volumn 36, Issue 7, 2006, Pages 474-475

  Anandacoomarasamy, A ^a   Gibson, J ^a   McGill, N ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCIUM; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DANAZOL; DAPSONE; HEPARIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; NIFEDIPINE; PAMIDRONIC ACID; PREDNISONE; RITUXIMAB; VINCRISTINE; VITAMIN D; WARFARIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; CASE REPORT; CORTICOSTEROID INDUCED OSTEOPOROSIS; DEEP VEIN THROMBOSIS; ENDOSCOPY; EROSIVE GASTRITIS; FEMALE; HEMOLYTIC ANEMIA; HUMAN; LETTER; LUNG EMBOLISM; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SUPPLEMENTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VASCULITIS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; IMMUNOLOGIC FACTORS;

EID: 33745039251     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2006.01113.x     Document Type: Letter

References (4)

1. Silverman GJ Weisman S. Rituximab therapy and autoimmune disorders. Arthritis Rheum 2003 48 : 1484 92.
2. Cooper N Stasi R Cunningham-Rundles S Feuerstein MA Leonard JP Amadori S et al. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br J Haematol 2004 125 : 232 9.
3. Looney RJ. B cell-targeted therapy in diseases other than rheumatoid arthritis. J Rheumatol Suppl 2005 73 : 25 8.
4. ten Cate R Smiers FJ Bredius RG Lankester AC van Suijlekom-Smit LW Huizinga TW et al. Anti-CD 20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus. Rheumatology 2004 43 : 244.